Very Insightful during Investor-and-Analyst-Meeting Updates on clinical and safety data from the AP26113 trial & more.. Read here http://www.earningsimpact.com/Transcript/82369/ARIA/Ariad-Pharmaceuticals%2c-Inc----Investor-and-Analyst-Meeting ARIA